AskBio
is a North Carolina-based biotechnology firm that researches and develops gene therapeutics for the treatment of genetic diseases... Read moreAskBio
is a North Carolina-based biotechnology firm that researches and develops gene therapeutics for the treatment of genetic diseases... Read more
News
Mar 11, 2025
Muscular Dystrophy News
AskBio: AB-1003 trial for LGMD proceeds after positive recommendation
Mar 07, 2025
The Korea Bizwire
AskBio: AskBio Advances Gene Therapy Clinical Trial for Limb-Girdle Muscular Dystrophy Type 2I/R9 with Dosing of First Participant in Second Cohort
Feb 20, 2025
PMLiVE
AskBio: FDA grants RMAT designation to AskBio's Parkinson's gene therapy candidate
Feb 18, 2025
Medthority
AskBio: Phase II Gene Therapy Trial for CHF
Jan 15, 2025
Pharmabiz
AskBio: AskBio begins patient randomizing in phase II gene therapy trial for Parkinson's disease
Nov 09, 2024
Pharmabiz
AskBio: AskBio receives US FDA rare paediatric disease & orphandrug designations for AB1003 to treat limbgirdle muscular dystrophy type 2I/R9
Oct 17, 2024
The Korea Bizwire
AskBio: AskBio Announces 11 Presentations at the European Society of Gene and Cell Therapy 31st Annual Meeting 2024
Sep 26, 2024
Pharamceutical Technology
AskBio: AskBio and Belief BioMed partner to advance gene therapies
Jun 27, 2024
Pharmabiz
AskBio: AskBio beings patient recruitment in REGENERATEPD phase 2 trial of AB1005 to treat Parkinson's disease
May 02, 2024
GlobalNewswire
Press Release: AskBio : AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting 2024
